Koch M - Search Results

1

Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors.

Potti A, Forseen SE, Koka VK, Pervez H, Koch M, Fraiman G, Mehdi SA, Levitt R. Potti A, et al. Among authors: koch m. Cancer Invest. 2004;22(4):537-44. doi: 10.1081/cnv-200026523. Cancer Invest. 2004. PMID: 15565811

2

Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma.

Potti A, Willardson J, Forseen C, Kishor Ganti A, Koch M, Hebert B, Levitt R, Mehdi SA. Potti A, et al. Among authors: koch m. Lung Cancer. 2002 Jun;36(3):257-61. doi: 10.1016/s0169-5002(01)00488-3. Lung Cancer. 2002. PMID: 12009234

3

Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma.

Koka V, Potti A, Koch M, Fraiman G, Mehdi S, Levitt R. Koka V, et al. Among authors: koch m. Anticancer Res. 2002 May-Jun;22(3):1593-7. Anticancer Res. 2002. PMID: 12168842

4

Identification and relationship of HER-2/neu overexpression to short-term mortality in primary malignant brain tumors.

Forseen SE, Potti A, Koka V, Koch M, Fraiman G, Levitt R. Forseen SE, et al. Among authors: koch m. Anticancer Res. 2002 May-Jun;22(3):1599-602. Anticancer Res. 2002. PMID: 12168843

5

HER-2/neu overexpression detected by immunohistochemistry in soft tissue sarcomas.

Foster H, Knox S, Ganti AK, Hebert BJ, Koch M, Tendulkar K, Levitt R, Potti A. Foster H, et al. Among authors: koch m. Am J Clin Oncol. 2003 Apr;26(2):188-91. doi: 10.1097/00000421-200304000-00018. Am J Clin Oncol. 2003. PMID: 12714894

6

Role of Her-2/neu overexpression and clinical determinants of early mortality in glioblastoma multiforme.

Koka V, Potti A, Forseen SE, Pervez H, Fraiman GN, Koch M, Levitt R. Koka V, et al. Among authors: koch m. Am J Clin Oncol. 2003 Aug;26(4):332-5. doi: 10.1097/01.COC.0000020922.66984.E7. Am J Clin Oncol. 2003. PMID: 12902879

7

Effect of pesticide exposure on HER-2/neu overexpression seen in patients with extensive stage small cell lung carcinoma.

Potti A, Ganti AK, Sholes K, Langness E, Koka V, Horvarth L, Koch M. Potti A, et al. Among authors: koch m. Clin Cancer Res. 2003 Oct 15;9(13):4872-6. Clin Cancer Res. 2003. PMID: 14581360

8

Immunohistochemical determination of HER-2/neu, c-Kit (CD117), and vascular endothelial growth factor (VEGF) overexpression in malignant melanoma.

Potti A, Moazzam N, Langness E, Sholes K, Tendulkar K, Koch M, Kargas S. Potti A, et al. Among authors: koch m. J Cancer Res Clin Oncol. 2004 Feb;130(2):80-6. doi: 10.1007/s00432-003-0509-8. Epub 2003 Nov 21. J Cancer Res Clin Oncol. 2004. PMID: 14634801

9

Immunohistochemical determination of HER-2/neu in malignant melanoma.

Potti A, Hille R, Koch M. Potti A, et al. Among authors: koch m. Anticancer Res. 2003 Sep-Oct;23(5A):4067-9. Anticancer Res. 2003. PMID: 14666720

10

Identification of HER-2/neu overexpression and the clinical course of lung carcinoma in non-smokers with chronic lymphocytic leukemia.

Potti A, Ganti AK, Koch M, Mehdi SA, Levitt R. Potti A, et al. Among authors: koch m. Lung Cancer. 2001 Nov;34(2):227-32. doi: 10.1016/s0169-5002(01)00241-0. Lung Cancer. 2001. PMID: 11679181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,969 results

Search Page

Filters